2OBU image
Entry Detail
PDB ID:
2OBU
Title:
Solution structure of GIP in TFE/water
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2006-12-20
Release Date:
2007-06-05
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
20
Selection Criteria:
target function
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Gastric inhibitory polypeptide
Chain IDs:A
Chain Length:42
Number of Molecules:1
Biological Source:
Ligand Molecules
Primary Citation
The bioactive conformation of glucose-dependent insulinotropic polypeptide by NMR and CD spectroscopy
Proteins 68 92 99 (2007)
PMID: 17393464 DOI: 10.1002/prot.21372

Abstact

Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal incretin hormone, which modulates physiological insulin secretion. Because of its glucose-sensitive insulinotropic activity, there has been a considerable interest in utilizing the hormone as a potential treatment for type 2 diabetes. Structural parameters obtained from NMR spectroscopy combined with molecular modeling techniques play a vital role in the design of new therapeutic drugs. Therefore, to understand the structural requirements for the biological activity of GIP, the solution structure of GIP was investigated by circular dichroism (CD) followed by proton nuclear magnetic resonance (NMR) spectroscopy. CD studies showed an increase in the helical character of the peptide with increasing concentration of trifluoroethanol (TFE) up to 50%. Therefore, the solution structure of GIP in 50% TFE was determined. It was found that there was an alpha-helix between residues 6 and 29, which tends to extend further up to residue 36. The implications of the C-terminal extended helical segment in the inhibitory properties of GIP on gastric acid secretion are discussed. It is shown that the adoption by GIP of an alpha-helical secondary structure is a requirement for its biological activity. Knowledge of the solution structure of GIP will help in the understanding of how the peptide interacts with its receptor and aids in the design of new therapeutic agents useful for the treatment of diabetes.

Legend

Protein

Chemical

Disease

Primary Citation of related structures